Sanofi wins FDA TB nod; UCB brings on Daiichi to market Vimpat in Japan;

> Sanofi ($SNY) has won FDA approval for Priftin tablets to treat latent tuberculosis infection. Release (PDF)

> Daiichi Sankyo has teamed up with UCB to commercialize epilepsy treatment Vimpat in Japan. Report

> Ranbaxy and Epirus have launched a biosimilar of Johnson & Johnson's ($JNJ) Remicade in India. More

> The EU has greenlighted Astellas' Xtandi for prechemo prostate cancer. Report

> Otsuka says new pickup Avanir's ($AVNR) sales and marketing capabilities can help it create a global CNS company. Release

And Finally... GlaxoSmithKline ($GSK) has named the winners for its drug-hunter challenge. More